Phototherapy-induced antitumor immunity: Long-term tumor suppression effects via photoinactivation of respiratory chain oxidase-triggered superoxide anion burst

Antioxidants and Redox Signaling

Volumn 24, Issue 5, 2016, Pages 249-262

  Lu, Cuixia ^a   Zhou, Feifan ^a,b   Wu, Shengnan ^a,b   Liu, Lei ^a   Xing, Da ^a,b  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLSERINE; SUPEROXIDE; SUPEROXIDE ANION BURST; UNCLASSIFIED DRUG; CYTOKINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE-FORMING ENZYME;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER THERAPY; CELL DEATH; CELL INFILTRATION; CELL MATURATION; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELIUM NEON LASER; HIGH FLUENCE LOW POWER LASER IRRADIATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PHOTOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY CHAIN; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MODEL; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; DRUG SCREENING; ELECTRON TRANSPORT; FEMALE; HUMAN; IMMUNOLOGY; LOW LEVEL LASER THERAPY; METABOLISM; MITOCHONDRION; NEOPLASMS; OXIDATION REDUCTION REACTION; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT; FEMALE; HUMANS; LOW-LEVEL LIGHT THERAPY; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MITOCHONDRIA; NADPH OXIDASE; NEOPLASMS; OXIDATION-REDUCTION; PHOTOTHERAPY; REACTIVE OXYGEN SPECIES; SUPEROXIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84956963157     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2015.6334     Document Type: Article

References (46)

1. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001
2. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, and Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs 5: 443-447, 1994
3. Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, and Witztum JL. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 200: 1359-1370, 2004
4. Chen X, Doffek K, Sugg SL, and Shilyansky J. Phosphatidylserine regulates the maturation of human dendritic cells. J Immunol 173: 2985-2994, 2004
5. da Silva RN, Silva AC, Maciel E, Simoes C, Horta S, Laranjeira P, Paiva A, Domingues P, and Domingues MR. Evaluation of the capacity of oxidized phosphatidylserines to induce the expression of cytokines in monocytes and dendritic cells. Arch Biochem Biophys 525: 9-15
6. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, and Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216, 1992
7. Gilbreath MJ, Nacy CA, Hoover DL, Alving CR, Swartz GM, Jr., and Meltzer MS. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. J Immunol 134: 3420-3425, 1985
8. Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, and Vile RG. Macrophages orchestrate the immune response to tumor cell death. Cancer Res 61: 7240-7247, 2001
9. Green DR, Ferguson T, Zitvogel L, and Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 9: 353-363, 2009
10. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, and Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 203: 2613-2625, 2006
11. Grivennikov SI, Greten FR, and Karin M. Immunity, inflammation, and cancer. Cell 140: 883-899, 2010
12. Guermonprez P, Valladeau J, Zitvogel L, Thery C, and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667, 2002
13. Hörkkö S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, and Witztum JL. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103: 117-128, 1999
14. Huang L, Wu S, and Xing D. High fluence low-power laser irradiation induces apoptosis via inactivation of Akt/GSK3beta signaling pathway. J Cell Physiol 226: 588-601, 2011
15. Huynh ML, Fadok VA, and Henson PM. Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109: 41-50, 2002
16. Jenne L, Arrighi JF, Jonuleit H, Saurat JH, and Hauser C. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Cancer Res 60: 4446-4452, 2000
17. Jiang J, Serinkan BF, Tyurina YY, Borisenko GG, Mi Z, Robbins PD, Schroit AJ, and Kagan VE. Peroxidation and externalization of phosphatidylserine associated with release of cytochrome c from mitochondria. Free Radic Biol Med 35: 814-825, 2003
18. Johnstone RW, Ruefli AA, and Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153-164, 2002
19. Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenstrom-Magnusson C, Liu SX, Serinkan FB, Arroyo A, Chandra J, Orrenius S, and Fadeel B. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J Immunol 169: 487-499, 2002
20. Kagan VE, Kuzmenko AI, Tyurina YY, Shvedova AA, Matsura T, and Yalowich JC. Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase. Cancer Res 61: 7777-7784, 2001
21. Kim R, Emi M, Tanabe K, and Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 66: 5527-5536, 2006
22. Kono H and Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289, 2008
23. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, and Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11, 2009
24. Mantovani A, Sozzani S, Locati M, Allavena P, and Sica A. Macrophage polarization: tumor-Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002
25. Mosser DM and Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969, 2008
26. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 407: 810-816, 2000
27. Noy R and Pollard JW. Tumor-Associated macrophages: from mechanisms to therapy. Immunity 41: 49-61, 2014
28. Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, and Elkon KB. Innate and adaptive immune response to apoptotic cells. J Autoimmun 29: 303-309, 2007
29. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, and Hazen SL. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 277: 38503-38516, 2002
30. Qian BZ and Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51
31. Reutelingsperger CP and van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 53: 527-532, 1997
32. Sanzen I, Imanishi N, Takamatsu N, Konosu S, Mantani N, Terasawa K, Tazawa K, Odaira Y, Watanabe M, Takeyama M, and Ochiai H. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (Maitake mushroom) in a macrophage cell line, RAW264.7. J Exp Clin Cancer Res 20: 591-597, 2001
33. Shaif-Muthana M, McIntyre C, Sisley K, Rennie I, and Murray A. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res 60: 6441-6447, 2000
34. Silverstein RL and Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2: re3, 2009
35. Smyth MJ, Dunn GP, and Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90: 1-50, 2006
36. Song S, Zhou F, Chen WR, and Xing D. PDT-induced HSP70 externalization up-regulates NO production via TLR2 signal pathway in macrophages. FEBS Lett 587: 128-135
37. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, and Moore KJ. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161
38. Tyurina YY, Kawai K, Tyurin VA, Liu SX, Kagan VE, and Fabisiak JP. The plasma membrane is the site of selective phosphatidylserine oxidation during apoptosis: role of cytochrome C. Antioxid Redox Signal 6: 209-225, 2004
39. Tyurina YY, Serinkan FB, Tyurin VA, Kini V, Yalowich JC, Schroit AJ, Fadeel B, and Kagan VE. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization andmacrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J Biol Chem279: 6056-6064, 2004
40. Wang F, Chen TS, Xing D, Wang JJ, and Wu YX. Measuring dynamics of caspase-3 activity in living cells using FRET technique during apoptosis induced by high fluence low-power laser irradiation. Lasers Surg Med 36: 2-7, 2005
41. Wu S, Xing D, Gao X, and Chen WR. High fluence lowpower laser irradiation induces mitochondrial permeability transition mediated by reactive oxygen species. J Cell Physiol 218: 603-611, 2009
42. Wu S, Xing D, Wang F, Chen T, and Chen WR. Mechanistic study of apoptosis induced by high-fluence lowpower laser irradiation using fluorescence imaging techniques. J Biomed Opt 12: 064015, 2007
43. Wu S, Zhou F, Wei Y, Chen WR, Chen Q, and Xing D. Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst. Antioxid Redox Signal 20: 733-746, 2014
44. Zhou F, Xing D, and Chen WR. Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells. Int J Cancer 125: 1380-1389, 2009
45. Zitvogel L, Apetoh L, Ghiringhelli F, Andre F, Tesniere A, and Kroemer G. The anticancer immune response: indispensable for therapeutic success? J Clin Invest 118: 1991-2001, 2008
46. Zitvogel L, Kepp O, and Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 140: 798-804, 2010